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ABSTRACT 
18
F-Fluoride PET-CT offers the opportunity for accurate skeletal metastasis staging 
compared to conventional imaging methods. 
18
F-Fluoride is a bone specific tracer whose 
uptake depends on osteoblastic activity. The osteoblastic process can also be detected 
morphologically in CT images due to the resulting increase in bone mineralization and 
sclerosis. Whilst CT is characterized by high resolution, the potential of PET is limited by 
its lower spatial resolution and the resulting partial volume effect. In this context, the 
synergy between PET and CT presents an opportunity to resolve this limitation using a 
novel multimodal approach called Synergistic-Functional-Structural Resolution-Recovery 
(SFS-RR). Its performance is benchmarked against current resolution recovery technology 
employing the point-spread-function (PSF) of the scanner in the reconstruction procedure. 
Methods - The SFS-RR technique takes advantage of the multiresolution property of the 
wavelet transform applied to both functional and structural images to create a high-
resolution PET that exploits the structural information of CT. Although the method was 
originally conceived for PET-MRI brain data, an ad-hoc version for whole body PET-CT is 
here proposed.  
Three phantom experiments and two datasets of metastatic bone 
18
F-Fluoride PET-CT 
images from primary prostate and breast cancer were used to test the algorithm 
performances. The SFS-RR images were compared with the manufacturer’s PSF based 
reconstruction using the standardized uptake value (SUV) and the metabolic volume as 
metrics for quantification.  
Results – When compared to standard PET images the phantom experiments showed a bias 
reduction of 14% in activity and 1.3cm
3 
in volume estimates for PSF images and up to 20% 
and 2.5cm
3 
for the SFS-RR images. The SFS-RR images were characterized by a higher 
recovery coefficient (up to 60%) while noise levels remained comparable to those of 
standard PET.  
The clinical data showed an increase in the SUV estimates for SFS-RR images up to 34% 
for SUVpeak and 50% for SUVmax and SUVmean. Images were also characterized by sharper 
lesion contours and better lesion detectability. 
! #!
Conclusion - The proposed methodology generates PET images with improved quantitative 
and qualitative properties. Compared to standard methods, SFS-RR provides superior 
lesion segmentation and quantification, which may result in more accurate tumor 
characterization. 
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INTRODUCTION 
Up to 70% of patients with prostate and breast cancer will develop bone 
metastases (1, 2). 
18
F-Fluoride has shown efficacy in both diagnosis and treatment response 
assessment (3-6) and recent studies on skeletal metastases report improved diagnostic 
sensitivity and specificity when morphologic evaluation from computed tomography (CT) 
scans are combined with functional evaluation of 
18
F-Fluoride positron emission 
tomography (PET) (7, 8). This radiotracer accumulates at skeletal metastatic sites as a 
result of increased blood flow, osteoblastic activity and bone mineralization (9-11). In 
prostate cancer, 
18
F-Fluoride accumulation corresponds to sites of osteosclerosis and 
increased bone density that are usually visible on CT (12). 
Evaluation criteria for tumor staging and response assessment include visual 
and/or quantitative evaluation of the extent, intensity and changes in 
18
F-Fluoride uptake in 
bone lesions (13). In this perspective the influence of the partial volume effect (PVE) is of 
impact (14) when comparing activity and morphological changes pre- and post- therapy 
(15, 16) considering the poor image resolution and quantification bias resulting from 
activity spill-over. PVE in PET has been addressed with several imaged-based partial 
volume correction (PVC) methods (17) that can be classified as either voxel-based 
methods, such as partition-based (18), multiresolution (19, 20), or region of interest (ROI)-
based techniques (21, 22), which are limited by assumptions of radiotracer distribution 
homogeneity in the area of interest. A distinct approach consists of the incorporation of a 
model for the system point-spread-function (PSF) within the image reconstruction 
algorithm to account for resolution degradation (23, 24).  
In this study our aim was to correct for the PVE in whole-body 
18
F-Fluoride PET-
CT to allow a more robust lesion classification in terms of activity quantification and 
volume definition. The methodology was developed from previous work by Shidahara et al 
(20) and exploits the local functional/structural relationship of PET-CT in a synergistic 
fashion for a realistic noise controlled resolution recovery of PET images, hence the name 
Synergistic-Functional-Structural Resolution-Recovery (SFS-RR). Here the SFS-RR 
algorithm is optimized for 
18
F-Fluoride PET given the correlation between functional 
(fluoride uptake) and morphological (sclerosis) signals on PET and CT images. For 
! %!
benchmarking the resulting images were compared to standard reconstructed PET images 
and images reconstructed with the inclusion of the PSF model (25). 
 
MATERIALS AND METHODS 
Image Resolution Recovery 
The Synergistic-Functional-Structural Resolution-Recovery (SFS-RR) algorithm 
was first introduced by Shidahara et al. (20) for partial volume correction of brain PET-MR 
data. The structural information was exploited by segmenting a T1-MRI image through a 
probability atlas (26) defining 83 anatomical regions. Hence, the resolution recovery is 
ROI-based and relies on good co-registration between PET and MRI images as well as 
between MRI and the probability atlas. The idea stems from previous concepts on wavelet-
based resolution recovery (19) and de-noising (27). 
In this work we developed SFS-RR further to fit a novel clinical requirement, 
specifically 
18
F-Fluoride PET-CT for detecting and monitoring bone metastases. The choice 
of the application is not fortuitous; in the first instance, PET-CT images provide synergistic 
information (i.e. both modalities show high image intensity in correspondence of lesions) 
and, secondly, they do not require additional coregistration as for two separate PET and 
MR acquisitions. Furthermore all the structural information of interest is contained in the 
CT and can be automatically segmented for each subject with no need for a universal atlas. 
The algorithm decomposes both functional (PET) and anatomical (CT) images into several 
resolution elements by means of a wavelet transform. The high-resolution components of 
both modalities are then combined together via a statistical model with appropriate scaling, 
resolution correction and weighting, to create a high-resolution PET image that exploits the 
structural information, when present, but preserves PET data when matching structural data 
are not present. 
 
Anatomical Image Segmentation 
In their original work, Shidahara et al. (20) proposed the use of an anatomical 
brain atlas to obtain suitable anatomical images. In brain studies this is a reasonable 
procedure given the possibility of normalizing to a common space (e.g. probabilistic atlas).  
! &!
In whole-body PET-CT, the atlas-based approach is not feasible. In 
18
F-Fluoride 
PET-CT acquisitions the good spatial correlation between morphological and functional 
information is such that the CT images of each subject can be processed individually to 
highlight the structures of interest supplying the required structural base.  
The first step consists of an initial coarse segmentation of the CT images based on 
thresholding the Hounsfield Units (HU) values as follow: bone (100≤HU<1400), soft tissue 
(0≤HU<100) and fat (-150≤HU<0) (28). 
Bone is further segmented into 100 bins after image histogram equalization. New intensity 
values are assigned to all the segmented regions. These intensity values are calculated from 
the average of each corresponding region in the original PET image to obtain the subject-
specific structural reference image used as anatomical information for the SFS-RR 
algorithm (20, 29) (Supplementary Materials Figure 1). 
Image segmentation and the SFS-RR algorithm implementation were both 
performed in Matlab R2011b (The Mathworks Inc., Natick MA, USA). The whole 
procedure is schematically described in Figure 1; for a more detailed mathematical 
exposition the reader is referred to the Supplementary Materials (Synergistic-Functional-
Structural Resolution Recovery Algorithm section).  
 
Phantom Data 
For the evaluation of the SFS-RR method we used the NEMA IEC body phantom 
and an insert with six spheres of different volumes, 26.52 cm
3
 (S1), 11.49 cm
3
 (S2), 5.57 
cm
3
 (S3), 2.57 cm
3
 (S4), 1.15 cm
3
 (S5) and 0.52 cm
3
 (S6), respectively. Compartments 
were filled with both iodinated contrast media (CM) Omnipaque300
TM
 (300 mg/ml organic 
Iodine) and radioactive tracer 
18
F-Fluoride. We aimed to reproduce contrast levels between 
different structures in both the PET and CT images as observed in clinical 
18
F-Fluoride 
bone scans. Specifically, we reproduced PET and CT contrasts as observed in normal soft 
tissue, normal bone and metastatic bone. We performed three different experiments 
changing the layout of CT and PET contrasts. This aimed to account for possible 
mismatches between functional and anatomical images (i.e. whereas a lesion would be 
detectable in only one imaging modality) resulting in a more robust method validation for 
! ∋!
what concern the phantom experiments. A summary of CM and radiotracer concentrations 
used in each experiment is reported in Table 1. For a detailed description of the 
experimental procedure we refer to Grecchi et al. 2014 (30). 
Images were acquired on a GE Discovery 710 PET-CT scanner (General Electric 
Medical System, Milwaukee, WI, USA). CT scans were performed with a routine clinical 
protocol (115 mA, 140 kVp and 0.5 second gantry rotation speed) followed by a fully 3D 
PET Time Of Flight (TOF) acquisition. PET data were reconstructed using our routine 
clinical protocol, a standard TOF Ordered Subsets Expectation Maximization (OSEM) 
algorithm (24 subsets, 2 iterations) (GE Q.Core VuePoint FX, henceforth called Standard 
PET). The resulting images were then processed with the SFS-RR algorithm. In addition 
we reconstructed the same data with the inclusion of a Point Spread Function (PSF) model 
into the standard TOF-OSEM algorithm (GE Q.Core VuePoint FX-S, henceforth called 
PET-PSF).  
All the images were finally smoothed with a Gaussian 3D filter FWHM 6.4mm; this is 
required by PSF reconstructed images as well when used in clinical routine given that 
increased noise level hamper visual assessment. 
 
Clinical Dataset 
The impact of the proposed resolution recovery technique was tested with two 
different sets of oncological patient data, both characterized by the presence of bone 
metastases. The institutional review board approved this study and all subjects signed a 
written informed consent. 
The first dataset was a prospective observational study of patients with bone-
predominant metastatic prostate cancer, at first diagnosis or at progression of disease, who 
were embarking on docetaxel chemotherapy. The second data set was a prospective 
observational study of patients with bone-predominant metastatic breast cancer, at first 
diagnosis or at progression of disease, who were embarking on a new line of endocrine 
treatment in combination with bone-targeted therapy. In total 7 patients with active skeletal 
metastases were included in the analysis, 4 with prostate cancer and 3 with breast cancer. 
! (!
In each patient a whole body 
18
F-Fluoride PET-CT scan was acquired with a total 
of 8 bed positions, from the base of the skull to upper thighs, 60 minutes after injection of  
approximately 250MBq.  
The image reconstruction protocol for both datasets was the same as for the 
phantom experiment, with the exclusion of the PSF reconstruction, which was not 
performed as it was not included in the clinical protocol.  
 
Data Analysis 
In-house software was used to perform quantitative analysis on both phantom and patient 
data. An ROI was manually drawn on the outer border of each lesion in order to completely 
contain the whole lesion volume (or sphere for the phantom data) and then automatically 
segmented with a threshold of 40% of the maximum value of the ROI. The SUVmean, 
SUVmax, SUVpeak and lesion metabolic active tumor volume (MATV) were then computed 
for the automatically segmented ROI. SUVpeak is computed here as the mean SUV 
measured over a fixed small circular volume of about 1cm
3
, in the hottest area of the tumor 
(more active region).  It is considered more reproducible since it involves the mean value of 
a few voxels involving and surrounding the hottest tumor area. 
Solely for the phantom experiments, knowing the ground truth, we used the Root Mean 
Square Error (RMSE) and Contrast to Noise Ratio (CNR) as additional metrics for image 
quality assessment. Specifically, we evaluated the quantification accuracy and the trade-off 
between contrast improvement and image noise. The two metrics are defined as follow 
!∀#∃ ! !∀∀!
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!!!represents the mean activity estimated inside a sphere and !!!!∀#∃! the corresponding 
ground truth while !!∀#∃!is the mean activity estimated in the phantom background and 
!!∀# its standard deviation. 
 
RESULTS 
Phantom Data 
! )!
Figure 2 shows representative transaxial views of structural (CT) and functional (PET) 
images for the three phantom experiments, one for each line. PET images from PSF 
reconstruction (PET-PSF) and from the application of the Resolution Recovery algorithm 
(PET-SFS) are also displayed. In Figure 2 Supplementary Material are reported as well 
representative line profiles for the three experiments for spheres 4-5.  
Improved qualitative resolution for the smaller structures (red marker in Figure 2) is noted 
when the SFS-RR algorithm is applied. Even though larger spheres (green and blue 
markers in Figure 2) are easily detectable in the images from all modalities, it is possible to 
appreciate a reduction in the blurring surrounding the structure when the resolution 
recovery algorithm is implemented.  
Furthermore it is possible to appreciate the robustness of the anatomy-based resolution 
recovery algorithm to unexpected mismatches between anatomy and functional acquisition 
by studying images from Experiment 1. Even though spheres 4-6 cannot be detected on the 
CT they are not lost in the new functional image returned by the SFS-RR algorithm.  
The quantitative evaluation of functional images obtained with the three different methods 
is reported in Table 2. The table reports for each phantom compartment in all the 
experiments the estimates of SUVmean, SUVmax, SUVpeak and MATV together with the 
corresponding ground-truth values.  
A summary of methods performances is summarized in the supplementary materials 
(Figure 3) as the average among the three experiments. The general trend shows that the 
smaller the sphere, the bigger the bias in the activity estimation, regardless of the method 
used. However, with the SFS-RR application the bias decreases with an average range of 1-
5% in the PET-PSF images and 5-19% in PET-SFS images. The same trend applies to 
lesion size estimation where the bias decreases in a range of 0.46-0.95 cm for PET-PSF 
data and 0.56-1.09 cm for PET-SFS data.  
The better performances of the SFS-RR algorithm are upheld by the root mean square error 
(RMSE) and contrast to noise ratio (CNR) comparison in Figure 3. Images resulting from 
the application of the SFS algorithm show lower RMSE on average (up to 15% compared to 
standard PET for the smallest sphere) while being consistent with the trend of the RMSE 
increasing for smaller spheres. It is of note that the improved image resolution does not 
! ∗!
come with a detriment of image quality as noise levels are contained with CNR either 
higher or comparable with the standard PET image. 
 
Clinical Dataset 
The influence of using the SFS-RR algorithm on real patient data can be appreciated 
qualitatively in Figure 4 (and Figures 4-6 in Supplementary Materials) where the Maximum 
Intensity Projection (MIP) and two different transaxial views are displayed for a 
representative subject. 
There is a clear increase in lesion sharpness following the application of a resolution 
recovery technique. The quantitative characterization of all lesions of this specific subject is 
reported in the Supplementary Materials (Figure 7 and Table 1). The transaxial views of 
Figure 4 is a good example of the effect in lesion definition and characterization using the 
SFS-RR algorithm. Sharper contours and the activity recovery in the PET-SFS images for 
the rib lesion (Figure 4, transaxial view, red marker) and also in the spine (Figure 4, 
transaxial view, blue marker) are evident, and in the spine lesion it is easier to appreciate 
that the activity is in the periphery of the lesion where there is greatest osteoblastic activity 
compared to the relatively photopenic center. In terms of quantitative characterization there 
is an increase in the SUVmean estimates of 60% (rib lesion, SUVPET =30.7 SUVSFS =49.1) and 
43% (spine lesion, SUVPET =23.2 SUVSFS =33.1) from the standard-PET to the PET-SFS. In 
contrast, the automatic segmented MATV has a relative reduction of 25% (rib lesion, 
MATVPET=2.7cm
3
 MATVSFS =2.1cm
3
) and 31% (spine lesion, MATVPET=7.5cm
3
 
MATVSFS=5.2cm
3
). 
A comprehensive comparison of the quantitative differences due to application of the SFS-
RR algorithm is reported in Figure 5. As previously performed for Patient 01 (Figure 7 -
Table 1 Supplementary Materials) we segmented all lesions of the remaining patients and 
collected the corresponding values of SUVmean, SUVmax, SUVpeak and MATV. Figure 5 
reports the relative differences (SUVs and MATV) between lesions segmented in standard 
PET and PET-SFS images for the entire datasets.  
There is a general increment in activity estimates for PET-SFS compared to standard PET. 
The average increments for different indexes are as follow: ΔSUVmean = 49%, ΔSUVmax = 
! ∀+!
47% and ΔSUVpeak = 34%. For low activity lesions the range of differences in the estimates 
is larger than for more active lesions indicating that the algorithm efficiency is dependent 
on signal to noise ratio. For the MATV there is an average reduction of 1.4cm
3
 when 
segmentation is performed on PET-SFS images. When lesion size increases the difference 
reached values of 4-5cm
3
, which might be relevant if patient classification were based on 
characterization of the larger detectable lesions. 
 
DISCUSSION 
In this work we evaluated the influence of a multimodal partial volume correction 
technique on the quantification and assessment of metastatic bone lesions from primary 
prostate and breast cancers. It is worth remarking that this work targets specifically to 
18
F-
Fluoride PET/CT bone scans as SFS-RR obviously produces better results the stronger is 
the correspondence between functional and structural signals. Our results showed an 
average 50% increase in SUVmax and SUVmean and a 30% increase in the SUVpeak for 
partial-volume corrected images when compared with the standard PET, depending on 
lesion size (lesion volume range 0.5–25cm
3
). Our results are in agreement with findings in 
similar experimental settings from previous studies (31, 32). Although SUVmax estimates 
depend on image noise, the 50% increase is not a consequence of noise bursts given the 
comparable RMSE between the SFS-RR corrected images and standard PET images.  
The higher activity recovery and the good noise control from the phantom analysis 
indicate a better image quality when the SFS-RR algorithm is applied. Indeed patient 
images show lesions with sharper and better-defined contours, which result in improved 
lesion conspicuity and segmentation even for smaller volumes. To note that the CNR 
depends on the absolute activity value and that explains why on Figure 3 one set of spheres 
show higher CNR than the other.  
The results from the phantom experiments showed that the SFS-RR images 
outperform both standard PET and PSF images in terms of image quality and quantification 
accuracy. PSF-based image reconstruction is known to contribute to the appearance of 
artefacts (33) and is computationally cumbersome hence is not performed in routine clinical 
studies in our Unit; for this reason standard PET was used as a reference for SFS-RR 
! ∀∀!
images when it came to patients image analysis. In this regard, it is worth noting that no 
artefacts have been generally observed in this and previous applications of SFS-RR which 
is now a mature enough technology worth further testing in the clinical setting. 
 It is worth highlighting the robustness of the methodology regarding possible 
mismatch between PET and CT images. Phantom acquisitions showed that even if some 
structures are only visible on the functional images, they are preserved after the application 
of the algorithm. This is of importance because lesions that might be lost in the CT 
segmentation, for example because their size is too small or the metastasis does not show 
sufficient bone mineralization to appear sclerotic, they will still be visible in the final 
enhanced PET images. 
Although the SFS-RR algorithm showed qualitatively and quantitatively better 
images than standard PET, further analyses are necessary to quantify the influence of the 
improved image quality on the assessment of patient skeletal staging and therapy response. 
This may allow better definition and quantification of lesions following therapy or allow 
greater detectability and segmentation of metastatic spread at staging. Of interest would be 
also to evaluate whether lesion heterogeneity is affected by higher resolution and evaluate 
the consequent impact on textural analysis, given its increasing oncological applications 
(34, 35). 
 
CONCLUSION 
We have proposed and tested on a set of phantom studies and demonstrated on clinical data 
a multimodal methodology for quantitative resolution recovery for whole body PET-CT, 
here specifically designed for 
18
F-Fluoride PET imaging of bone metastases. The technique 
allows rapid and straightforward application and! ,−./0123! 456723! .8! 3479484169:!
45,−.;2/!;4306<!=06<4:>!69/!=069:4:6:4;2!,−.,2−:423? 
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!Figure 1 Graphical representation of the SFS-RR algorithm. A) The structural reference 
image required by the SFS-RR algorithm is computed from the CT and PET images; B) 
wavelet decomposition of functional and structural images; C) the functional and structural 
wavelet coefficients are combined to get the new high-resolution PET coefficients; D) 
inverse wavelet transform of the coefficients obtained from step C resulting in the new 
high-resolution SFS-RR PET image. For a detailed mathematical formulation refer to the 
Supplementary Materials. 
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Figure 2 [
18
F]Fluoride PET-CT transaxial images of three different phantom experiment 
acquisitions (one for each line). Alongside the CT image (1
st
 column) are three different 
type of functional images: standard PET images (2
nd
 column), images resulting from the 
inclusion of a PSF model into the reconstruction (3
rd
 column) and images resulting after the 
application of the SFS resolution recovery algorithm (4
th
 column).  
For detailed information on lesions volume, CM and 18F-FDG concentrations we refer to 
Table 1. 
Green markers highlight sphere 2, blue markers highlight sphere 4 and red markers 
highlight sphere 6. 
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Figure 3 Root mean square error and noise analysis. For each sphere (S1-S6) three values 
corresponding to images obtained with different modalities are reported: standard PET 
(dashed circle), PET with PSF reconstruction (white triangle) and PET corrected with SFS-
RR algorithm (black diamond)  
A) Root mean square error for the six spheres obtained as an average among the three 
phantom experiments. B-C) Contrast to noise ratio computed for each sphere against a 
uniform region in the phantom background. Only experiments 1 and 2 are reported for 
consistency reasons (in experiment 3 three spheres have zero activity). 
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Figure 4 Maximum Intensity Projection (MIP) and transaxial views of a representative 
subject (Patient 01). Left Panel - Standard PET; Right Panel - PET corrected with SFS-RR 
algorithm. The red and blue markers highlight two representative lesions (spine and rib 
respectively) that appear sharper in the PET-SFS image compared to the standard PET one. 
Dashed lines indicate the slice position of the transaxial views reported below the MIP. 
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Figure 5 Bland-Altman plots showing the differences in MATV and activity quantification 
when estimates are computed in images obtained with standard PET and PET corrected 
with the SFS-RR algorithm. Each grey circle represents a specific lesion; all lesions of all 
patients are reported. The differences between estimates for SUVmean (A), SUVmax (B) and 
SUVpeak (C) are reported as the relative percentage difference. The MATV (D) is reported 
as absolute difference in cm
3
. 
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TABLES 
Table 1 
CT CONTRAST MEDIA AND PET RADIOTRACER CONCENTRATIONS  
Phantom 
Compartments 
Experiment 1 Experiment 2 Experiment 3  
Iodine CM 
[mg/ml] 
18F-FDG 
[kBq/ml] 
Iodine CM 
[mg/ml] 
18F-FDG 
[kBq/ml] 
Iodine CM 
[mg/ml] 
18F-FDG 
[kBq/ml] 
Sphere Volume 
[ml] 
Background 1.08 * 4.56 * 1.20 * 5.29 * 1.20 * 5.70 * 9700 
S1 6.00 † 53.20 † 6.00 † 66.50 † 1.20 * 5.70 * 26.52 
S2 6.00 † 53.20 † 42.00 ‡ 187.00 ‡ 41.20 ‡ 227.00 ‡ 11.49 
S3 6.00 † 53.20 † 6.00 † 66.50 † 1.20 * 5.70 * 5.57 
S4 1.00 * 148.50 ‡ 42.00 ‡ 187.00 ‡ 41.20 ‡ 227.00 ‡ 2.57 
S5 1.00 * 148.50 ‡ 6.00 † 66.50 † 1.20 * 5.70 * 1.15 
S6 1.00 * 148.50 ‡ 42.00 ‡ 187.00 ‡ 41.20 ‡ 227.00 ‡ 0.52 
Concentrations of Iodine (from Omnipaque300
TM
) and 
18
F-FDG injected in all phantom 
compartments for each experiment. Compartments volumes are also reported. 
To note that spheres 4-6 Experiment 1 and spheres 1,3,5 Experiment 3 are filled with the 
same radioactivity concentration as the background – as a result they are indiscernible in 
the PET image. 
 
* Concentration resulting in image contrast comparable to normal soft tissue 
† Concentration resulting in image contrast comparable to normal bone 
‡ Concentration resulting in image contrast comparable to metastatic bone 
 
 
 
